InBody Co.,Ltd (KOSDAQ:041830)
44,350
-1,850 (-4.00%)
Jun 12, 2026, 3:30 PM KST
InBody Co.,Ltd Revenue
InBody Co.,Ltd had revenue of 68.44B KRW in the quarter ending March 31, 2026, with 23.14% growth. This brings the company's revenue in the last twelve months to 246.81B, up 16.63% year-over-year. In the year 2025, InBody Co.,Ltd had annual revenue of 233.95B with 14.42% growth.
Revenue (ttm)
246.81B
Revenue Growth
+16.63%
P/S Ratio
2.40
Revenue / Employee
721.66M
Employees
342
Market Cap
591.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 233.95B | 29.48B | 14.42% |
| Dec 31, 2024 | 204.46B | 34.11B | 20.03% |
| Dec 31, 2023 | 170.35B | 10.35B | 6.47% |
| Dec 31, 2022 | 160.00B | 22.17B | 16.08% |
| Dec 31, 2021 | 137.84B | 30.71B | 28.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seegene | 487.37B |
| i-SENS | 314.31B |
| WON TECH | 159.67B |
| DRTECH | 122.78B |
| Osang Healthcare Co.,Ltd | 119.38B |
| L&C BIO Co.,LTD | 98.10B |
| Bio Plus | 94.42B |
| SEERS | 76.63B |